Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis. Authors' reply-Reference-Cited by-同舟云学术

Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis. Authors' reply

Published:2023-12-12 Issue:1 Volume:59 Page:124-125
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Tyson Luke D.¹²^ORCID,Atkinson Stephen¹²³,Hunter Robert W.⁴,Thursz Mark¹²,Vergis Nikhil¹²³

Affiliation:

1. Department of Metabolism, Digestion and Reproduction Imperial College London London UK

2. The Liver Unit St Mary's Hospital London UK

3. GSK Stevenage UK

4. Centre for Cardiovascular Science University of Edinburgh Edinburgh UK

Abstract

LINKED CONTENTThis article is linked to Tyson et al papers. To view these articles, visit https://doi.org/10.1111/apt.17733 and https://doi.org/10.1111/apt.17771

Funder

Medical Research Council

Health Technology Assessment Programme

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17786

Reference4 articles.

1. In severe alcohol‐related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL‐8 and micro‐RNAs

2. Editorial: Unmasking the silent threat—acute kidney injury in alcohol‐associated hepatitis

3. GawriehS DasarathyS TuW KamathPS ChalasaniNP McClainCJ.Anakinra plus zinc versus prednisone for treatment of severe alcohol‐associated hepatitis: a randomized controlled trial. poster presented at: the Liver Meeting; American Association for the Study of Liver Diseases. Published 2022. Accessed January 6 2023https://www.aasld.org/sites/default/files/2022‐11/2022%20Late%20Breaking%20Abstracts%20rev2.pdf